Bioventus Inc (BVS) support and resistance · rev $573.3M
Bioventus Inc (BVS) is a medical devices company listed on US.
This page maps Bioventus Inc (BVS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
BVS currently screens at market cap $495.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BVS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BVS quote page for the session range and the stock page for the full model.
Not investment advice.